Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STARSTIM: SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY

NCT04770337 is registered in ClinicalTrials.gov with Neuroelectrics Corporation as lead sponsor.

NCT NCT04770337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STARSTIM: SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY
Lead sponsor
Neuroelectrics Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 25, 2021
Completion date
January 12, 2026
Enrollment
127 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, epilepsy in children, epilepsy, tonic-clonic, focal seizure, refractory epilepsy, seizures, seizures, focal